Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more
Predictive Oncology Inc (POAI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, Predictive Oncology Inc (POAI) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.65 Million) by net assets ($-77.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Predictive Oncology Inc - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Predictive Oncology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Predictive Oncology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Predictive Oncology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Central China Real Estate Limited
PINK:CNLLF
|
-0.352x |
|
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS
|
0.097x |
|
First Physicians Capital Group Inc
PINK:FPCG
|
-0.005x |
|
BLACKROCK (BLQA.SG)
STU:BLQA
|
0.032x |
|
Cords Cable Industries Limited
NSE:CORDSCABLE
|
0.141x |
|
ArborGen Holdings Limited
PINK:RUBNF
|
-0.051x |
|
Lukas Biomedical Inc.
TWO:6814
|
-0.138x |
|
Century Extrusions Limited
NSE:CENTEXT
|
0.095x |
Annual Cash Flow Conversion Efficiency for Predictive Oncology Inc (2008–2024)
The table below shows the annual cash flow conversion efficiency of Predictive Oncology Inc from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-202.61K | $-11.96 Million | 59.008x | +3800.73% |
| 2023-12-31 | $8.27 Million | $-13.19 Million | -1.595x | -180.55% |
| 2022-12-31 | $21.77 Million | $-12.37 Million | -0.568x | -87.45% |
| 2021-12-31 | $40.27 Million | $-12.21 Million | -0.303x | +93.46% |
| 2020-12-31 | $2.64 Million | $-12.26 Million | -4.638x | -496.57% |
| 2019-12-31 | $11.23 Million | $-8.73 Million | -0.778x | +99.21% |
| 2018-12-31 | $53.47K | $-5.29 Million | -98.890x | -5869.03% |
| 2017-12-31 | $2.69 Million | $-4.46 Million | -1.657x | +65.07% |
| 2016-12-31 | $923.68K | $-4.38 Million | -4.743x | -160.55% |
| 2015-12-31 | $4.11 Million | $-7.49 Million | -1.821x | -397.87% |
| 2014-12-31 | $-5.52 Million | $-3.37 Million | 0.611x | -48.98% |
| 2013-12-31 | $-3.22 Million | $-3.86 Million | 1.198x | +234.13% |
| 2012-12-31 | $-3.30 Million | $-1.18 Million | 0.358x | -45.61% |
| 2011-12-31 | $-2.70 Million | $-1.78 Million | 0.659x | +75.84% |
| 2010-12-31 | $-2.19 Million | $-820.68K | 0.375x | -32.99% |
| 2009-12-31 | $-2.34 Million | $-1.31 Million | 0.559x | -80.78% |
| 2008-12-31 | $-309.44K | $-900.53K | 2.910x | -- |